Ticker Details
Alto Neuroscience Inc.
IPO Date:	February 2, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.35B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.64 | 6.34%
Avg Daily Range (30 D):	$0.88 | 3.09%
Avg Daily Range (90 D):	$1.31 | 14.53%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.36M

Trade Size
Avg Trade Size (Sh.):	97
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	226
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.7M
Avg Institutional Trade (90 D):	$2.09M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.59M
Avg Closing Trade (30 D):	$1.49M
Avg Closing Trade (90 D):	$2.45M
Avg Closing Volume:	142.02K

News

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Oct 7, 2025 @ 10:05 PM ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi... Source: Bragar Eagel & Squire, P.C.

Sep 19, 2025 @ 8:49 PM Investors who lost money on Alto Neuroscience, Inc... Source: Levi & Korsinsky, Llp

Sep 19, 2025 @ 1:50 PM ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA... Source: Rosen Law Firm

Sep 18, 2025 @ 8:00 PM ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$-.65	$-.8
Diluted EPS		$-.65	$-.8
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-27.64M	$-26.24M
Operating Income / Loss		$-29.13M	$-27.14M
Cost of Revenue
Net Cash Flow		$-20.03M	$87.28M
PE Ratio